FDA Foreign Inspections User Fee Program Getting Push On The Hill
This article was originally published in The Tan Sheet
Executive Summary
The pharmaceutical industry faces an increasingly aggressive push to create user fees for manufacturing inspections.
You may also be interested in...
FDA Global Pharma Safety Plan Looks To Food Model
FDA seeks new authority over the international drug supply chain to support a global safety plan.
House Investigation Of Tainted Heparin Could Highlight Need For Import Safety Legislation - Or Not
Energy and Commerce Republicans seek to determine who contaminated heparin supplies in 2008, how they did it, and why FDA has failed to answer those questions as the panel begins oversight of the agency.
Companies Reveal Hurdles In Providing Drugs Via Expanded Access Programs
GSK, Stealth BioTherapeutics and Blueprint Medicines discuss the difficulties getting participation of physicians, the excessive cost of expanded access, and whether physicians should report research data.